U.S. Electronic Equipment and Components Stock News

Elanco Animal Health (ELAN) shares have drifted slightly in recent trading sessions, moving down just under 1% today. Despite this minor fluctuation, the company’s stock remains up more than 26% over the past 3 months. See our latest analysis for Elanco Animal Health. Elanco’s recent momentum is hard to miss. The company has posted a 7-day share price return of more than 8 percent and a 93 percent gain year to date. While some volatility is a given, these moves follow operational progress and...

Wondering if Advanced Drainage Systems could be undervalued or is living up to its price tag? You are not alone, as many investors are weighing whether there is room to run or if now is the time to reconsider. The shares have climbed 7.1% in the past week, are up 34.3% year-to-date, and have returned an impressive 119.1% over the last five years. These movements reflect shifting market optimism and long-term potential. Recent headlines have highlighted the company's continued expansion in...

Wondering if GameStop's current stock price could be an opportunity in disguise? Let's examine what the numbers and latest sentiment suggest about its value and future potential. Shares have been on a wild ride lately, jumping 5.9% in the last week but still down 8.1% over the past month and nearly 30% year-to-date. GameStop has once again captured headlines due to renewed attention from retail trading communities, as well as ongoing discussions around its evolving business model and changes...

Wondering if Edison International is presenting a real buying opportunity right now? Let’s break down if the current stock price actually offers value, or if there is more to the story than meets the eye. The stock has bounced back 2.8% in the past week and is up 3.9% for the last 30 days, though it is still down a steep 26.1% year-to-date and 29.2% over the past year, making many investors question where it might go next. Recent headlines have zeroed in on regulatory challenges and...

Wondering if Weyerhaeuser is a hidden bargain or just treading water? If you are looking for clues on whether the current share price spells opportunity or risk, you are in the right place. The stock has seen a bumpy ride lately, gaining 4.3% over the past week but still down 7.3% over the last month and a steep 20.5% lower year-to-date. Recent headlines highlight a combination of shifting investor sentiment across the real estate sector, along with a renewed focus on timberland as a...

Bath & Body Works (BBWI) issued its third quarter earnings and updated its 2025 outlook, revealing declines in both sales and net income compared to last year. The updated guidance pointed to softer sales and profits ahead. See our latest analysis for Bath & Body Works. The latest quarter’s muted results and downward revision to full-year sales guidance have weighed heavily on sentiment, with the stock’s share price return slipping 33.3% over the past month and 54.2% year-to-date. Long-term...

Ever wondered if Iridium Communications is a hidden bargain or a value trap? You are not alone, especially as more investors are re-examining the stock this year. The share price has swung noticeably, up 1.5% this week but still down over 44% year-to-date and more than 43% in the past year, shaping new perceptions around risk and potential growth. Recently, headlines about satellite launches and new partnerships for global connectivity have provided a fresh context to Iridium's price shifts...

Curious whether Signet Jewelers is really a hidden gem or if the shine has already worn off? Let’s dig into what makes this stock worth a closer look, especially if value matters to you. It has been an eventful stretch for Signet Jewelers, with the stock up 9.6% over the past week and 32.6% year-to-date. This suggests that investor sentiment has shifted, and growth potential is now being considered. Recently, the company attracted headlines with its strategic expansion into omni-channel...

Western Midstream Partners (WES) has delivered solid year-over-year growth, with revenue and net income both up around 7% and 9%, respectively. Investors keeping an eye on the midstream sector may find these trends worth noting. See our latest analysis for Western Midstream Partners. Western Midstream Partners’ share price has been treading water for much of the year, even as the broader energy sector remains active. Its one-year total shareholder return of nearly 8% hints at the steady...

Ever wondered if Carnival Corporation & is still a bargain or if its recent price action has changed the picture? Let’s take a look at the story behind the numbers. Carnival Corporation & shares are up 156.1% over three years, but have dipped 2.5% in the last week and are down 13.6% over the past month. This hints at shifting perceptions among investors. News about Carnival’s ongoing fleet revitalization and persistent consumer demand for cruises continues to make headlines. This fuels...

MarketAxess Holdings (MKTX) has seen its stock move quietly in recent sessions, drawing investor attention as the company’s performance this year remains under the microscope. Shares are trading near $164, following a challenging past 3 months for the broader sector. See our latest analysis for MarketAxess Holdings. Despite a challenging stretch in the sector, MarketAxess Holdings’ share price has slipped further, with momentum fading as the year-to-date share price return registers at...

Curious whether Elevance Health is trading at a bargain or if you might be overpaying? Let's dig into the numbers to get you the insight you're looking for on where value really lies. This month, Elevance Health shares have jumped 7.0% over the past week but are still down 1.2% over the last 30 days and remain off 14.4% compared to a year ago. Recent headlines have focused on healthcare sector volatility and changes in policy that could influence managed care organizations like Elevance...

Wondering if AST SpaceMobile’s recent hype means the stock is a bargain or riding high on speculation? You are not alone. Figuring out real value is more important than ever with this kind of momentum. With shares up 156.6% year-to-date and showing a 138.4% gain over the last 12 months, AST SpaceMobile is drawing a lot of attention, even as the stock dipped 4.3% in the past week and 30.1% over the last month. The rollercoaster in price comes as investors digest a wave of headlines about the...

Celanese (CE) shares have seen some movement recently, prompting investors to consider where the stock might go from here. With global markets in flux, there is a growing sense of curiosity about the company’s current value and future prospects. See our latest analysis for Celanese. Celanese’s share price has swung up and down in recent months, with an 11.98% rally over the last week hinting at a rebound. However, the year-to-date share price return is still down 40.84%. Both short- and...

Wondering whether Kontoor Brands might be a hidden gem or simply priced just right? If recent chatter about finding value in overlooked consumer brands has you interested, you are in the right place. Kontoor Brands’ stock has shown some spirited movement lately, climbing 7.2% in the past week, even though it remains down 12.7% year to date and 15.8% lower than a year ago. The stock’s recent swings come as the company has been featured in industry news for its product...

Cboe Global Markets (CBOE) has been on investors' radars lately, with its stock delivering nearly 20% over the past year and showing strong momentum over the past month. The company continues to adapt to changing market conditions in the global exchange and trading landscape. See our latest analysis for Cboe Global Markets. Momentum is clearly building for Cboe Global Markets, with a 1-month share price return of 8.3% and a 1-year total shareholder return near 20%. Over both the short and...

If you have ever wondered whether Datadog’s stock is currently a steal or sitting at a premium, you are far from alone. Let’s dig into what might be driving its value. Despite a choppy week with the stock dropping 10.2%, Datadog has managed to climb 10.3% year-to-date and is up an impressive 109% over the past three years. Recent headlines have centered on Datadog's expansion of its AI-driven monitoring tools and the announcement of new strategic partnerships. These developments have stirred...

Wondering if TechnipFMC could be a smart buy or potentially overhyped? You are not alone, as plenty of investors are eyeing its value story right now. The stock has been on a strong run lately, climbing 2.9% over the last week, 11.6% in the last month, and a remarkable 53.0% year-to-date. Much of this momentum comes after recent news highlighting large offshore contract wins and continued optimism around energy infrastructure spending, which have fueled bullish investor sentiment and kept...

In recent days, Rothschild Redburn initiated coverage on Saia Inc. with a Neutral rating and highlighted the company's ongoing network expansion and robust five-year revenue growth trajectory, while also noting recent margin pressures. An interesting insight is that, despite margin challenges from accepting lower-quality shipments, Saia exceeded third-quarter 2025 earnings forecasts, reflecting operational strength in a competitive transportation market. We will explore how the recent...

Cadence Design Systems (CDNS) has recently caught fresh attention after Citigroup began covering the stock with a Buy, highlighting renewed optimism around the company’s outlook. Analysts are focusing on Cadence’s dominant position in electronic design automation and its durable growth potential. See our latest analysis for Cadence Design Systems. This upbeat analyst sentiment builds on a year of major moves for Cadence Design Systems, including the appointment of Dr. Luc Van den hove to its...

Aurinia Pharmaceuticals (AUPH) shares have been steadily gaining ground this month. This trend reflects investor optimism around the company’s performance in the autoimmune therapeutics space. Recent trading shows a positive momentum for the stock. See our latest analysis for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' 1-month share price return of 33.2% is part of an even stronger year-to-date rally, with shares climbing 86.66%. The stock’s 1-year total shareholder return stands at...

QuidelOrtho (QDEL) shares have experienced some movement recently, as investors weigh the company’s latest performance data and ongoing business developments. This activity comes amid a pivot in the healthcare diagnostics market along with shifting industry trends. See our latest analysis for QuidelOrtho. QuidelOrtho’s shares have been on a rollercoaster lately, with a strong 7-day share price return of 31.01% capturing investor attention after months of weakness. Still, the stock’s...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Preformed Line Products fair value estimate is US$186...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...